The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)

被引:117
作者
Bonhoeffer, J [1 ]
Kohl, K
Chen, R
Duclos, P
Heijbel, H
Heininger, U
Jefferson, T
Loupi, E
机构
[1] Univ Basel, Childrens Hosp, CH-4003 Basel, Switzerland
[2] Ctr Dis Control, Atlanta, GA 30333 USA
[3] WHO, CH-1211 Geneva, Switzerland
[4] Swedish Inst Infect Dis Control, Stockholm, Sweden
[5] Cochrane Vaccines Field & Hlth Reviews Ltd, Rome, Italy
[6] Aventis Pasteur SA, Leon, France
关键词
immunization; safety; AEFI; standardization; case definition;
D O I
10.1016/S0264-410X(02)00449-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To further scientific progress of immunization safety, comparability of data from clinical trials and surveillance systems is essential. Comparability requires the availability of standardized case definitions for adverse events following immunization (AEFI) and guidelines for case determination, recording and data presentation. Method: International collaborative working groups, consisting of professional volunteers from developed and developing countries, conduct systematic literature reviews to develop 50-100 AEFI definitions. Case definitions are finalized after a comment period by a reference group consisting of organizations concerned with immunization safety, and will be disseminated via the world-wide-web and other means for free world-wide use. Results: Literature reviews yielded substantial diversity in data collection and presentation. We have developed standardized case definitions together with guidelines for use in clinical trials and surveillance systems. Conclusions: Diversity in safety methods leads to considerable loss of scientific information. We have built the necessary international network of currently about 300 participants from patient care, public health, scientific, pharmaceutical, regulatory and professional organizations to develop and assess standardized AEFI case definitions and guidelines. Evaluation studies, global implementation, ongoing definition development and a continuously growing network will be essential for the success of the collaboration. Published by Elsevier Science Ltd.
引用
收藏
页码:298 / 302
页数:5
相关论文
共 30 条
  • [1] BLUMBERG DA, 1993, PEDIATRICS, V91, P1158
  • [2] Report of a US Public Health Service Workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization
    Braun, MM
    Terracciano, G
    Salive, ME
    Blumberg, DA
    Vermeer-de Bondt, PE
    Heijbel, H
    Evans, G
    Patriarca, PA
    Ellenberg, SS
    [J]. PEDIATRICS, 1998, 102 (05)
  • [3] Vaccine risks: real, perceived and unknown
    Chen, RT
    [J]. VACCINE, 1999, 17 : S41 - S46
  • [4] THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)
    CHEN, RT
    RASTOGI, SC
    MULLEN, JR
    HAYES, SW
    COCHI, SL
    DONLON, JA
    WASSILAK, SG
    [J]. VACCINE, 1994, 12 (06) : 542 - 550
  • [5] CODY CL, 1981, PEDIATRICS, V68, P650
  • [6] Reactogenicity and immunogenicity of a new combined Measles-Mumps-Rubella vaccine: results of a multicentre trial
    Crovari, P
    Gabutti, G
    Giammanco, G
    Dentico, P
    Moiraghi, AR
    Ponzio, F
    Soncini, R
    [J]. VACCINE, 2000, 18 (25) : 2796 - 2803
  • [7] Fescharek R, 1998, Dev Biol Stand, V95, P203
  • [8] Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service
    Gold, M
    Goodwin, H
    Botham, S
    Burgess, M
    Nash, M
    Kempe, A
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (02) : 128 - 131
  • [9] Gold R, 1997, Can Commun Dis Rep, V23, P73
  • [10] Vaccination of children following a previous hypotonic-hyporesponsive episode
    Goodwin, H
    Nash, M
    Gold, M
    Heath, TC
    Burgess, MA
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1999, 35 (06) : 549 - 552